A Real-World Retrospective Analysis of Secondary Prevention Patients Treated with Inclisiran over 27 Months
{{output}}
ASCVD is a global concern as it has become central to significant morbidity and mortality. LDL-C is the most important modifiable risk factor in developing ASCVD. Therefore, lowering LDL-C levels is paramount to tackling ASCVD; the lower the LDL-C, the better.... ...
